theophylline has been researched along with Diabetes Mellitus, Type 1 in 19 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A single dose of theophylline improves hypoglycemia unawareness in type 1 diabetic patients." | 9.10 | Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia. ( de Galan, BE; Lenders, JW; Lutterman, JA; Smits, P; Tack, CJ, 2003) |
| " Since theophylline increases cAMP (by inhibiting its decomposition), we investigated the effect of theophylline on glucose recovery after insulin-induced hypoglycemia." | 9.07 | Theophylline enhances glucose recovery after hypoglycemia in healthy man and in type I diabetic patients. ( Christensen, NJ; Hilsted, J; Hvidberg, A; Rasmussen, MH, 1994) |
| "A single dose of theophylline improves hypoglycemia unawareness in type 1 diabetic patients." | 5.10 | Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia. ( de Galan, BE; Lenders, JW; Lutterman, JA; Smits, P; Tack, CJ, 2003) |
| " Since theophylline increases cAMP (by inhibiting its decomposition), we investigated the effect of theophylline on glucose recovery after insulin-induced hypoglycemia." | 5.07 | Theophylline enhances glucose recovery after hypoglycemia in healthy man and in type I diabetic patients. ( Christensen, NJ; Hilsted, J; Hvidberg, A; Rasmussen, MH, 1994) |
| " In this study we tested the hypothesis that long-term administration of theophylline might augment glucose recovery after insulin-induced hypoglycaemia." | 2.69 | Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with type 1 diabetes mellitus. ( Christensen, NJ; Hilsted, J; Hvidberg, A; Rosenfalck, A, 1998) |
| "The authors have studied the effect of rubella virus infection on human pancreatic islet cells in tissue culture." | 1.28 | Infection of cultured human fetal pancreatic islet cells by rubella virus. ( Goldman, H; Numazaki, K; Wainberg, MA; Wong, I, 1989) |
| "In 23 recent-onset IDDM patients, lymphocyte sensitivity in vitro to theophylline was tested both in basal conditions and after improvement of metabolic control." | 1.27 | Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. ( Ciboddo, GF; Crosti, F; Falqui, L; Ferrero, E; Inverardi, L; Pavoni, D; Pontiroli, AE; Protti, P; Rugarli, C; Secchi, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groot Nibbelink, M | 1 |
| Marchioli, G | 1 |
| Moroni, L | 1 |
| Karperien, M | 1 |
| Van Apeldoorn, A | 1 |
| Salama, A | 1 |
| Mosser, M | 1 |
| Lévêque, X | 1 |
| Perota, A | 1 |
| Judor, JP | 1 |
| Danna, C | 1 |
| Pogu, S | 1 |
| Mouré, A | 1 |
| Jégou, D | 1 |
| Gaide, N | 1 |
| Abadie, J | 1 |
| Gauthier, O | 1 |
| Concordet, JP | 1 |
| Le Bas-Bernardet, S | 1 |
| Riochet, D | 1 |
| Le Berre, L | 1 |
| Hervouet, J | 1 |
| Minault, D | 1 |
| Weiss, P | 1 |
| Guicheux, J | 1 |
| Brouard, S | 1 |
| Bosch, S | 1 |
| Lagutina, I | 1 |
| Duchi, R | 1 |
| Lazzari, G | 1 |
| Cozzi, E | 1 |
| Blancho, G | 1 |
| Conchon, S | 1 |
| Galli, C | 1 |
| Soulillou, JP | 1 |
| Bach, JM | 1 |
| de Galan, BE | 2 |
| Tack, CJ | 2 |
| Lenders, JW | 2 |
| Lutterman, JA | 2 |
| Smits, P | 2 |
| Buschard, K | 3 |
| Madsbad, S | 1 |
| Rygaard, J | 1 |
| Korrapati, MR | 1 |
| Vestal, RE | 1 |
| Loi, CM | 1 |
| Scharp, DW | 1 |
| Swanson, CJ | 1 |
| Olack, BJ | 1 |
| Latta, PP | 1 |
| Hegre, OD | 1 |
| Doherty, EJ | 1 |
| Gentile, FT | 1 |
| Flavin, KS | 1 |
| Ansara, MF | 1 |
| Lacy, PE | 1 |
| Hvidberg, A | 2 |
| Rasmussen, MH | 1 |
| Christensen, NJ | 2 |
| Hilsted, J | 2 |
| Karlsson, E | 1 |
| Stridsberg, M | 1 |
| Sandler, S | 1 |
| Rosenfalck, A | 1 |
| Bock, T | 1 |
| Pedersen, CR | 1 |
| Hansen, SV | 1 |
| Aaen, K | 1 |
| Jørgensen, M | 1 |
| Hansen, MW | 1 |
| Kjaer, TW | 1 |
| Hageman, I | 1 |
| Josefsen, K | 1 |
| Pasman, JW | 1 |
| Elving, LD | 1 |
| Russel, FG | 1 |
| Burn, JH | 1 |
| Sodoyez-Goffaux, F | 1 |
| Sodoyez, JC | 1 |
| Numazaki, K | 1 |
| Goldman, H | 1 |
| Wong, I | 1 |
| Wainberg, MA | 1 |
| Crosti, F | 1 |
| Secchi, A | 1 |
| Ferrero, E | 1 |
| Falqui, L | 1 |
| Inverardi, L | 1 |
| Pontiroli, AE | 1 |
| Ciboddo, GF | 1 |
| Pavoni, D | 1 |
| Protti, P | 1 |
| Rugarli, C | 1 |
| Darquy, S | 1 |
| Reach, G | 1 |
| Chiumello, G | 1 |
| Del Guercio, MJ | 1 |
| Di Natale, B | 1 |
| Devetta, M | 1 |
| Caccamo, A | 1 |
| Carroll, KF | 1 |
| Nestel, PJ | 1 |
1 review available for theophylline and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
Topics: Animals; Antibodies, Viral; Cyclophosphamide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Ty | 1985 |
5 trials available for theophylline and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia.
Topics: Adult; Analysis of Variance; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, | 2003 |
Theophylline metabolism in healthy nonsmokers and in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Indians | 1995 |
Theophylline enhances glucose recovery after hypoglycemia in healthy man and in type I diabetic patients.
Topics: Adult; Blood Glucose; Cyclic AMP; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Synergism; Gl | 1994 |
Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with type 1 diabetes mellitus.
Topics: Adult; Blood Glucose; Cyclic AMP; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Humans; Hy | 1998 |
Theophylline improves hypoglycemia unawareness in type 1 diabetes.
Topics: Adult; Awareness; Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Type 1; Epinephrine; Femal | 2002 |
13 other studies available for theophylline and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
A Protocol to Enhance INS1E and MIN6 Functionality-The Use of Theophylline.
Topics: Animals; Cell Line; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Humans; In Vitro Te | 2016 |
Neu5Gc and α1-3 GAL Xenoantigen Knockout Does Not Affect Glycemia Homeostasis and Insulin Secretion in Pigs.
Topics: Animals; Antigens, Heterophile; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Galactose; Gene | 2017 |
Plasma from insulin-dependent diabetics inhibits theophylline sensitive T-lymphocytes demonstrated in E-rosette assay.
Topics: Adult; Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 1; Female; Glucose; Glycosuria; Histoc | 1983 |
Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects.
Topics: Biocompatible Materials; Blood Glucose; Cell Survival; Diabetes Mellitus, Type 1; Diabetes Mellitus, | 1994 |
Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice.
Topics: Amyloid; Animals; Cattle; Culture Techniques; Diabetes Mellitus, Type 1; Disease Models, Animal; DNA | 1996 |
Neonatal treatment with beta-cell stimulatory agents reduces the incidence of diabetes in BB rats.
Topics: Animals; Animals, Newborn; Arginine; Diabetes Mellitus, Type 1; Drug Combinations; Female; Glucagon; | 2000 |
Early observations and their importance today. I. Diabetes in childhood, II. Theophylline in myasthenia gravis, III. Properties of cod liver oil.
Topics: Bronchitis; Child; Cod Liver Oil; Diabetes Mellitus, Type 1; Diet; Fish Oils; Glucose; Humans; Myast | 1978 |
Transient diabetes mellitus in a neonate. Evaluation of insulin, glucagon, and growth hormone secretion and management with a continuous low-dose insulin infusion.
Topics: Adolescent; Antigens; Blood Glucose; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance | 1977 |
Infection of cultured human fetal pancreatic islet cells by rubella virus.
Topics: Antigens, Viral; Cells, Cultured; Diabetes Mellitus, Type 1; Fetus; Fluorescent Antibody Technique; | 1989 |
Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, Surface; Blood Glucose; Concanavalin A; Diabete | 1986 |
Immunoisolation of pancreatic B cells by microencapsulation. An in vitro study.
Topics: Alginates; Animals; Antibodies; Arginine; Chromium Radioisotopes; Complement System Proteins; Cytoto | 1985 |
B-pancreatic function in obese and diabetic children.
Topics: Arginine; Blood Glucose; Child; Diabetes Mellitus, Type 1; Ethylenediamines; Female; Glucagon; Gluco | 1972 |
Diurnal variation in glucose tolerance and in insulin secretion in man.
Topics: Administration, Oral; Adolescent; Adult; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; | 1973 |